On Invalid Date, ABBOTT LABORATORIES (NYSE: ABT) reported Q1 2022 earnings per share (EPS) of $1.38, up 38% year over year. Total ABBOTT LABORATORIES earnings for the quarter were $2.45 billion. In the same quarter last year, ABBOTT LABORATORIES's earnings per share (EPS) was $1.00.
What was ABT's earnings growth in the past year?
As of Q2 2022, ABBOTT LABORATORIES's earnings has grown 35.94% year over year. This is 24.1 percentage points lower than the US Medical Devices industry earnings growth rate of 60.04%. ABBOTT LABORATORIES's earnings in the past year totalled $7.73 billion.
What is ABT's earnings date?
ABBOTT LABORATORIES's earnings date is Invalid Date. Add ABT to your watchlist to be reminded of ABT's next earnings announcement.
What was ABT's revenue last quarter?
On Invalid Date, ABBOTT LABORATORIES (NYSE: ABT) reported Q1 2022 revenue of $11.90 billion up 13.76% year over year. In the same quarter last year, ABBOTT LABORATORIES's revenue was $10.46 billion.
What was ABT's revenue growth in the past year?
As of Q2 2022, ABBOTT LABORATORIES's revenue has grown 19.22% year over year. This is 2.08 percentage points lower than the US Medical Devices industry revenue growth rate of 21.3%. ABBOTT LABORATORIES's revenue in the past year totalled $44.51 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.